About V.A.C. VERAFLO Therapy

V.A.C. VERAFLO Therapy combines the benefits of V.A.C.® Therapy with automated topical wound solution distribution and removal. It can help:

Cleanse

the wound with instillation of topical wound cleansers in a consistent, controlled manner

Treat

the wound with the instillation of appropriate topical antimicrobial and antiseptic solutions and the removal of infectious material

Heal

the wound and prepare for primary or secondary closure

V.A.C. VERAFLO Therapy is designed for patients who would benefit from vacuum-assisted drainage and controlled delivery of topical cleansing solutions over the wound bed.

Specialized Dressings

V.A.C. VERAFLO Therapy uses dressings specifically designed for instillation therapy with NPWT. The dressings are similar to the V.A.C.® GRANUFOAM Dressing but are less hydrophobic and have greater strength to allow for improved distribution of topical wound solutions across the wound bed.

Instillation with dwell time (NPWTi-d):

A controlled, automated process in which instilled topical wound solution is slowly introduced into the wound and remains in the wound bed for a defined period of time before being removed by applying negative pressure.

When wound debridement is delayed or isn't possible or appropriate, consider:
Cleansing the wound with V.A.C. VERAFLO CLEANSE CHOICE Dressing: The unique three-layer design in conjunction with V.A.C. VERAFLO Therapy, facilitates removal of thick wound exudate, such as fibrin, slough, and other infectious material from a variety of complex wounds

Wound Characteristics: Wounds with thick wound exudate, such as fibrin, slough, and infectious material

V.A.C. VERAFLO CLEANSE
CHOICE DRESSING VIDEO

When the wound needs a combination of granulation and cleansing, consider:
V.A.C. VERAFLO Dressing:
available in 3 sizes

Wound Characteristics:
Open wounds, including wounds with shallow undermining or tunnel areas where the distal aspect is visible

When you need an easy to apply dressing for tunneling and undermining, consider:
V.A.C. VERAFLO CLEANSE Dressing:
provides flexibility in addressing wounds with complex geometries (Note: does not contain silver)

Wound Characteristics:
Wounds with complex geometries, including explored tunnels or undermining where the distal aspect is not visible

Indicated Open Wound Types

● Acute, traumatic

● Dehisced

● Chronic

● Pressure Ulcers

● Diabetic foot ulcers

● Venous ulcers

The V.A.C. VERAFLO Dressing Kits include the V.A.C.® Advanced Drape with improved moisture resistant properties compared to V.A.C.® Drape and also 3M Cavilon No Sting Barrier Film, V.A.C. VERAT.R.A.C. Pad and Tubing Set or V.A.C. VERAT.R.A.C. Duo and Tubing Set, plus a disposable ruler.

To learn more about V.A.C. VERAFLO Therapy Dressings, watch our nurse video. For additional information about V.A.C. VERAFLO Therapy, visit www.acelity.com. If using the V.A.C.ULTA 4-Therapy System the V.A.C.ULTA 4-Therapy System User Manual is available for review or review the V.A.C.ULTA Therapy System User Manual

NPWTi-d solutions

There are a variety of topical solutions that are FDA-cleared and compatible with V.A.C. VERAFLO Therapy. Compatible means that the solution is still the same when it touches the wound as it was in the bottle or bag and has not changed the properties of the V.A.C. VERAFLO Therapy components. Normal saline may be used as the instillation solution, or a solution with different characteristics may be chosen by the treating clinician.

Instillation with dwell time (NPWTi-d):

A controlled, automated process in which instilled topical wound solution is slowly introduced into the wound and remains in the wound bed for a defined period of time before being removed by applying negative pressure.

Solutions Compatible with V.A.C. VERAFLO Therapy*

Use the side tabs or swipe to view the next compatible solution.

  • Generic Solution Class

    Hypochlorite-based solutions
    (e.g., hypochlorous acid,
    sodium hypochlorite)

    Trade Name

    Dakin’s Solution (quarter strength), Dermacyn® (Oculus Innovative Sciences, Inc.), Microcyn® (Oculus Innovative Sciences, Inc.), Vashe® (PuriCore Inc.)

    Considerations for Use with V.A.C VERAFLO Therapy

    • Dakin’s Solution should not be used in concentrations greater than 0.125% (quarter strength).
    • Consider using the fewest irrigation cycles and minimizing hold times to the lowest level that is clinically relevant.
  • Generic Solution Class

    Silver nitrate (0.5%)

    Trade Name

    Various

    Considerations for Use with V.A.C VERAFLO Therapy

    • Silver nitrate is light-sensitive. Protect V.A.C. VERALINK Instillation Tubing from light during use of silver nitrate.
  • Generic Solution Class

    Sulfur-based solutions
    (sulfonamides)

    Trade Name

    Mafenide acetate, Sulfamylon® (Mylan Institutional Inc.)

    Considerations for Use with V.A.C VERAFLO Therapy

    Refer to manufacturer’s labeling for solution-specific considerations. No device-related considerations for use with V.A.C. VERAFLO Therapy.

  • Generic Solution Class

    Biguanides (polyhexanide)

    Trade Name

    Prontosan® (B. Braun Medical, Inc.)

    Considerations for Use with V.A.C VERAFLO Therapy

    • May need to be transferred to a container that can be accessed with a spike.
  • Generic Solution Class

    Cationic solutions (octenidine, benzalkonium chloride)

    Trade Name

    Octenilin® (Schülke & Mayr GmbH)

    Considerations for Use with V.A.C VERAFLO Therapy

    • Refer to manufacturer’s labeling for solution-specific considerations. No device-related considerations for use with V.A.C. VERAFLO Therapy.
  • Generic Solution Class

    Isotonic solutions

    Trade Name

    Normal Saline Solution, Lactated Ringer’s Solution

    Considerations for Use with V.A.C VERAFLO Therapy

    • Refer to manufacturer’s labeling for solution-specific considerations. No device-related considerations for use with V.A.C. VERAFLO Therapy.
  • Generic Solution Class

    Local anesthetic (topical wound cleanser additive)

    Trade Name

    Lidocaine

    Considerations for Use with V.A.C VERAFLO Therapy

    • Lidocaine hydrochloride without any other additives should only be used in concentrations equal to or less than 0.1%.
    • Refer to manufacturer’s labeling for solution-specific considerations. No device-related considerations for use with V.A.C. VERAFLO Therapy.
    • Toxicity concerns may exist; consult with your Pharmacist for solution- and patient- specific considerations when using lidocaine hydrochloride as an additive to topical wound cleansing solutions.
Generic Solution Class Trade Name Considerations for Use with V.A.C VERAFLO Therapy

Hypochlorite-based solutions
(e.g., hypochlorous acid,
sodium hypochlorite)

Dakin’s Solution (quarter strength), Dermacyn® (Oculus Innovative Sciences, Inc.), Microcyn® (Oculus Innovative Sciences, Inc.), Vashe® (PuriCore Inc.)

  • Dakin’s Solution should not be used in concentrations greater than 0.125% (quarter strength).
  • Consider using the fewest irrigation cycles and minimizing hold times to the lowest level that is clinically relevant.

Silver nitrate (0.5%)

Various

  • Silver nitrate is light-sensitive. Protect V.A.C. VERALINK Instillation Tubing from light during use of silver nitrate.

Sulfur-based solutions
(sulfonamides)

Mafenide acetate, Sulfamylon® (Mylan Institutional Inc.)

Refer to manufacturer’s labeling for solution-specific considerations. No device-related considerations for use with V.A.C. VERAFLO Therapy.

Biguanides (polyhexanide)

Prontosan® (B. Braun Medical, Inc.)

  • May need to be transferred to a container that can be accessed with a spike.

Cationic solutions (octenidine, benzalkonium chloride)

Octenilin® (Schülke & Mayr GmbH)

  • Refer to manufacturer’s labeling for solution-specific considerations. No device-related considerations for use with V.A.C. VERAFLO Therapy.

Isotonic solutions

Normal Saline Solution, Lactated Ringer’s Solution

  • Refer to manufacturer’s labeling for solution-specific considerations. No device-related considerations for use with V.A.C. VERAFLO Therapy.

Local anesthetic (topical wound cleanser additive)

Lidocaine

  • Lidocaine hydrochloride without any other additives should only be used in concentrations equal to or less than 0.1%.
  • Refer to manufacturer’s labeling for solution-specific considerations. No device-related considerations for use with V.A.C. VERAFLO Therapy.
  • Toxicity concerns may exist; consult with your Pharmacist for solution- and patient- specific considerations when using lidocaine hydrochloride as an additive to topical wound cleansing solutions.

*Caution: Listing of the above solutions is neither an endorsement nor an indication of a solution’s clinical efficacy. These solutions are included based on KCI in-house testing of disposables, mechanical properties, biocompatibility, and solution interaction and found to be compatible with the V.A.C.ULTA™ Therapy System components. If wound healing goals are not being achieved, consider an alternate instillation frequency, solution concentration, or solution type deemed appropriate by a physician. Please follow solution manufacturer’s Instructions for Use prior to use with V.A.C. VERAFLO Therapy.

To learn more about how to choose V.A.C. VERAFLO Therapy solutions, watch our nurse video

Dwell/soak time

The length of the soak time depends on the recommendations of the solution manufacturer and the goal of therapy. For example, when using Prontosan® Wound Irrigation Solution, the dwell/soak time recommended by the manufacturer is at least 15 minutes.

 

Only V.A.C. VERAFLO Therapy allows for customized NPWTi-d, because no two wounds are the same. Variables to consider when determining the ideal dwell/soak time:

  • Anatomical location of the wound
  • Complexity of the wound
  • If the patient is ambulatory
  • If the patient adheres or is compliant with the plan of care

To learn more about determining dwell/soak time, watch our nurse video

Fill Assist feature

Fill Assist allows the user to monitor initial wound fill by manually starting and stopping instillation to determine correct instill volume after the dressing is applied. Once determined, this volume will automatically be delivered for each subsequent instillation with dwell time phase of V.A.C. VERAFLO Therapy.

Instillation with dwell time (NPWTi-d):

A controlled, automated process in which instilled topical wound solution is slowly introduced into the wound and remains in the wound bed for a defined period of time before being removed by applying negative pressure.

Dressing soak

The dressing soak tool allows you to soak the dressing in the wound with topical wound solution before changing the dressing, allowing for easier dressing removal and increased patient comfort.

Seal Check Leak Detector

This tool can help you find negative pressure leaks in the system through the use of audible tones and on-screen visual aids during the troubleshooting process. The Seal Check feature takes 2.5 minutes on initial drawdown, which may seem like a long time, but it enables you to be assured that the seals have been established.

 

To learn more about how to apply V.A.C. VERAFLO Therapy, view our Tips and Techniques and FAQs pages.

  • Dwell/soak time

    The length of the soak time depends on the recommendations of the solution manufacturer and the goal of therapy. For example, when using Prontosan® Wound Irrigation Solution, the dwell/soak time recommended by the manufacturer is at least 15 minutes.

     

    Only V.A.C. VERAFLO Therapy allows for customized NPWTi-d, because no two wounds are the same. Variables to consider when determining the ideal dwell/soak time:

    • Anatomical location of the wound
    • Complexity of the wound
    • If the patient is ambulatory
    • If the patient adheres or is compliant with the plan of care

    To learn more about determining dwell/soak time, watch our nurse video

  • Fill Assist feature

    Fill Assist allows the user to monitor initial wound fill by manually starting and stopping instillation to determine correct instill volume after the dressing is applied. Once determined, this volume will automatically be delivered for each subsequent instillation with dwell time phase of V.A.C. VERAFLO Therapy.

    Instillation with dwell time (NPWTi-d):

    A controlled, automated process in which instilled topical wound solution is slowly introduced into the wound and remains in the wound bed for a defined period of time before being removed by applying negative pressure.

  • Dressing soak

    The dressing soak tool allows you to soak the dressing in the wound with topical wound solution before changing the dressing, allowing for easier dressing removal and increased patient comfort.

  • Seal Check Leak Detector

    This tool can help you find negative pressure leaks in the system through the use of audible tones and on-screen visual aids during the troubleshooting process. The Seal Check feature takes 2.5 minutes on initial drawdown, which may seem like a long time, but it enables you to be assured that the seals have been established.

     

    To learn more about how to apply V.A.C. VERAFLO Therapy, view our Tips and Techniques and FAQs pages.

For additional information about V.A.C. VERAFLO Therapy, visit www.acelity.com. If using the V.A.C.ULTA 4-Therapy System the V.A.C.ULTA 4-Therapy System User Manual is available for review or review the V.A.C.ULTA Therapy System User Manual

CAUTION: Federal law restricts this device to sale/rental by or on the order of a physician. Dermacyn and Microcyn are registered trademarks of Oculus Innovative Sciences, Inc. Octenelin is a registered trademark of Schülke & Mayr GmbH. Prontosan is a registered trademark of B. Braun Medical, Inc. Sulfamylon is a registered trademark of Mylan Institutional Inc. Vashe is a registered trademark of PuriCore Inc.

X